A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

Journal of Psychopharmacology

Volumn 17, Issue 1, 2003, Pages 113-119

  Niederhofer, Helmut ^a   Staffen, Wolfgang ^a   Mair, Alois ^a  

^a Christian Doppler Klinik   (Austria)

Author keywords

Attention deficit hyperactivity disorder; Lofexidine; Tic disorder

Indexed keywords

CLONIDINE; LOFEXIDINE; NORTRIPTYLINE; PLACEBO;

ADOLESCENT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; MALE; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SEDATION; SIDE EFFECT; TIC; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; XEROSTOMIA;

ADOLESCENT; ADRENERGIC AGONISTS; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CHILD; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERVIEWS; MALE; NEUROPSYCHOLOGICAL TESTS; TIC DISORDERS; TREATMENT OUTCOME;

EID: 0037349733     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881103017001714     Document Type: Article

References (60)

1. Akhurst J S (1999) The use of lofexidine by drug dependency units in the United Kingdom. Eur Addict Res 5:43-49
2. Avery R, Franowicz J C S, Studholme C, van Dyck C H, Arnsten A F T (2000) The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex and improves accuracy in monkeys performing a spatial working memory task. Neuropsychopharmacology 23: 240-249
3. Barkley R A, McMurray M B, Edelbrock C S, Robbins K (1992) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86: 184-192
4. Barrickman L, Perry P, Allen A, Kuperman S, Arndt S, Herrmann K, Schumacher E (1995) Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34: 649-657
5. Berridge C W, Foote S L (1991) Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11: 3135-3145
6. Biederman J, Jellinek MS (1984) Current concepts. Psychopharmacology in children. N Engl J Med 310: 968-972
7. Biederman J, Baldessarini R J, Wright V, Knee D, Harmatz J S (1989) A double-blind placebo controlled study of desipramine in the treatment of ADD, I: efficacy. J Am Acad Child Adolesc Psychiatry 28: 777-784
8. Borcherding B G, Keysor C S, Rapoport J L, Elia J, Amass J (1990) Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res 33: 83-94
9. Brown A S, Fleming P M (1998) A naturalistic study of home detoxification from opiates using lofexidine. J Psychopharmacol 12: 93-96
10. Buitelaar J K, Van der Gaag R J, Swaab-Barneveld H, Kuiper M (1996) Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder: clinical efficacy and side-effects. J Child Psychol Psychiatry 37: 587-595
11. Buzsaki G, Kennedy B, Solt V B, Ziegler M (1991) Noradrenergic control of thalamic oscillation: the role of a-2 receptors. Eur J Neurol 3: 222-229
12. Carnwath T, Hardman J (1998) Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal. Drug Alcohol Depend 50: 251-254
13. Casey B J, Castellanos F X, Giedd J N, Marsh W L, Hamburger S D, Schubert A B, Vauss Y C, Vaituzis A C, Dickstein D P, Sarfatti S E, Rapoport J L (1997) Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolescent Psychiatry 36: 374-383
14. Cohen D J, Young J G, Nathanson J A, Shaywitz B A (1979) Clonidine in Tourette's syndrome. Lancet 2: 551-553
15. Connor D F, Barkley R A, Davis H T (2000) A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr 39: 15-25
16. Conners C K, Barkley R A (1985) Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull 21: 809-843
17. Conners C K, Casat C D, Gualtieri C T, Weller E, Reader M, Reiss A, Weller R A, Khayrallah M, Ascher J (1996) Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 34:1314-1321
18. Crenshaw T M, Kavale K A, Forness S R, Reeve R E (1999) Attention deficit hyperactivity disorder and the efficacy of stimulant medication: a meta-analysis. In Scruggs T E, Mastropieri M A (eds), Advances in learning and behavioral disabilities, vol. 13, pp. 135-165. JAI Press, Greenwich, CT
19. DuPaul G J, Anastopoulos A D, Power T J, Reid R, Ikeda M J, MacGoey K E (1998a) Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathol Behav Assess 20: 57-81
20. DuPaul G J, Anastopoulos A D, MacGoey K E, Power T J, Reid R, Ikeda M J (1998b) Teacher ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. Psychol Assess 9: 436-444
21. Engberg G, Eriksson E (1991) Effects of a-2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in EEDQ-treated rats. Naunyn Schmiedebergs Arch Pharmacol 343: 472-477
22. Eggers C H, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 237: 223-229
23. Erenberg G, Cruse R P, Rothner A D (1985) Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology 35: 1346-1348
24. Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, et al. (1996) A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 46: 965-968
25. Gadow K D, Sverd J, Sprafkin J, Nolan E E, Ezor S N (1995) Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 52: 444-455
26. Gadow K D, Sverd J, Sprafkin J, Nolan E E, Grossman S (1999) Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 56: 330-336
27. Goetz C G, Tanner C M, Wilson R S, Carroll V S, Como P G, Shannon K M (1987) Clonidine and Gilles de la Tourette syndrome: double-blind study using objective rating methods. Ann Neurol 21:307-310
28. Gowing L, Farrell M, Ali R, White J (2001) Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 1: CD002024
29. Goyette C H, Conners C K, Ulrich R F (1978) Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 6: 221-236
30. Greenhill L L, Abikoff H B, Arnold L E, Cantwell D P, Conners C K, Elliott G, Hechtman L, Hinshaw S P, Hoza B, Jensen P S, March J S, Newcorn J, Pelham W E, Severe J B, Swanson J M, Vitiello B, Wells K (1996) Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35: 1304-1313
31. Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, Ringel R, Shaddy R, Taubert K (1999) Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation 99: 979-982
32. Guy W (1976) ECDEU assessment manual for psychopharmacology: Publication ADM 76-338, pp. 218-222. US Department of Health, Education, and Welfare, Washington, DC
33. Hunt R D, Minderaa R B, Cohen D J (1985) Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psychiatry 24: 617-629
34. Jin Y, Elko E E, Tran T, Yorio T (1989) Inhibition of adenylate cyclase in bovine ciliary process and rabbit iris ciliary body to alpha 2-adrenergic agonists. J Ocul Pharmacol 5:189-197
35. Jin Y, Verstappen A, Elko E, Cammarata P, Yorio T (1992) Effects of Lofexidine, an alpha 2-adrenoreceptor agonist, on ocular blood flow and ion transport of rabbit iris-ciliary body. J Ocul Pharmacol 8: 23-33
36. Katz N L, Sobaski N, Sanchez J, Young J E, Schlemmer R F (1989) Differential effects of clonidine analogs on food intake in rabbits and monkeys. Pharmacol Biochem Behav 34: 433-437
37. Law S F, Schachar R J (1999) Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38: 944-951
38. Leckman J F, Ort S, Caruso K A, Anderson G M, Riddle M A, Cohen D J (1986) Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Arch Gen Psychiatry 43: 1168-1176
39. Leckman J F, Riddle M A, Hardin M T, Ort S I, Swartz K L, Stevenson J, Cohen D J (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28: 566-573
40. Leckman J F, Hardin M T, Riddle M A, Stevenson J, Ort S I, Cohen D J (1991) Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48: 324-328
41. Leckman J F, King R A, Scahill L, Findley D, Ort S I, Cohen D J (1999) Yale approach to assessment and treatment, in Tourette's syndrome. In Leckman J F, Cohen D J (eds), Tics, obsessions, compulsions: developmental psychopathology and clinical care, pp. 285-309. John Wiley & Sons, New York
42. Levine J, Schooler N (1986) SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22:343-381
43. Li B M, Mao Z M, Wang M, Mei Z T (1999) Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology 21: 601-610
44. Lipkin P H, Goldstein I J, Adesman A R (1994) Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 148: 859-861
45. Lowe T L, Cohen D J, Detlor J, Kremenitzer M W, Shaywitz B A (1982) Stimulant medications precipitate Tourette's syndrome. JAMA 26: 1729-1731
46. Nass R, Bressman S (2002) Attention deficit hyperactivity disorder and Tourette syndrome - what is the best treatment? Neurology 58:513-514
47. National Heart, Lung and Blood Institute (1987) Report of the Second Task Force on Blood Pressure Control in Children - 1987. Pediatrics 79: 1-25
48. Rapport M D, Denney C, DuPaul G J, Gardner M J (1994) Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 33: 882-893
49. Riddle M A, Geller B, Ryan N (1993) Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 32: 792-797
50. Riddle M A, Lynch K A, Scahill L, deVries A, Cohen D J, Leckman J F (1995) Effects of methylphenidate discontinuation and reinitiation in children with Tourette's syndrome and ADHD. J Child Adolesc Psychopharmacol 5: 205-214
51. Rosvold H E, Mirsky A F, Sarason I, Bransome E D, Beck L H (1956) A continuous performance test of brain damage. J Consult Psychol 20: 343-350
52. Sallee F R, Kurlan R, Goetz C, Singer H, Scahill L, Law G, Dittman V M, Chappell P B (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39: 292-299
53. Scahill L, Riddle M A, McSwiggin-Hardin M, Ort S I, King R A, Goodman W K, Cicchetti D, Leckman J F (1997) Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36: 844-852
54. Shapiro E, Shapiro A K, Fulop G, Hubbard M, Mandell J, Nordlie J, Phillips R A (1989) Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46: 722-730
55. Singer H, Brown J, Quaskey S, Rosenberg L A, Mellits E D, Denckla M B (1995) The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 95: 74-81
56. Sorkin E M, Heel R C (1986) Guanfacine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of hypertension. Drugs 31: 301-336
57. Strang J, Bearn J, Gossop M (1999) Lofexidine for opiate detoxification: review of randomised and open controlled trials. Am J Addict 4: 337-348
58. Swanson J M, Wigal S, Greenhill L L, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell D P (1998) Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 37: 519-526
59. Wilson M F, Haring O, Lewin A, Bedsole G, Stepansky W, Fillingim J, Hall D, Roginsky M, McMahon F G, Jagger P, Strauss M (1986) Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension. Am J Cardiol 57: 43E-49E
60. Zito J M, Safer D J, dosReis S, Gardner J F, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283: 1025-1030